Abstract Aims-Chromosome llq23 seems to be a site of frequent mutation in cancer. It also contains loci such as ataxia telangiectasia with possible importance in the pathogenesis of breast tumours. The short arm of chromosome 11 has been studied extensively in breast cancer, but the long arm, in particular the distal part, has been studied less frequently. Cytogenetic analysis has shown possible involvement of chromosome llq in breast tumours. 
Many cancers have mutations at or near chromosome band 11 q23. Particular examples include haematological malignancies, colorectal tumours, ovarian cancer,' and malignant melanoma.3 Chromosome 1 1 q23 also carries several genes, such as the ataxia telangiectasia (AT) complementation groups and Fanconi anaemia (FA) complementation group D,4 that may be involved in cancer predispostion.
In breast cancer chromosome lip has been studied extensively, with mapping of a putative tumour suppressor gene to band p 1pl5.5.5 The long arm of chromosome 11 has been analysed less frequently, especially the distal part. Cytogenetic analysis, however, has shown possible involvement of chromosome 11 q in breast tumours, especially in patients with metastatic disease.i' Chromosome transfer experiments have also implicated 11 q in breast cancer.'
We have used restriction fragment analysis to search for mutations in this region of the genome in 41 cases of sporadic breast carcinoma. We report the frequency of mutations at the NCAM, DRD2, INT2 (FGF3), D11S29, ETS1, and DllZl loci (table 1) . Each patient's age at presentation was known, and tumour stage, grade and origin were determined histologically. Associations between mutations and the clinical data have also been determined. fig 1. The highest mutant frequency was found at D 1I S29, with 59% of informative cases having lost an allele. At NCAM, the frequency of allelic loss was 14%. The results at NCAM, however, are complicated by the finding of allelic rearrangements in a substantial proportion of patients (21% of informative and 14% of non-informative cases). These rearrangements were seen as one or more additional bands of less than 9-8 kilobases on the autoradiographs, present in tumours only, and of sizes different from the normal alleles detected by the gene probe used (fig 1 B) The results presented provide further evidence for the importance of gene(s) near 11 q23 in tumorigenesis. Further work on additional patients may (1) confirm or refute the association between metastasis and allelic loss at D 1S29 and investigate the reasons for this observation; (2) enable the allelic rearrangements at NCAM to be proven and characterised; and (3) allow the region(s) of most frequent mutation to be mapped. Candidate loci include the AT group,'6 FA group D4 and the progesterone receptor.'7 NCAM itself is a candidate locus and although little is known about its expression in breast tissue, it has been implicated in haematological malignancies,'8 small cell lung cancer'9 and colorectal cancer.20
Methods
It must also be determined whether the loci involved are the same or different in each type of cancer that shows mutations at or near 1 q23.
